Startseite Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents

  • Mary Kathryn Bohn , Siobhan Wilson , Randal Schneider , Youssef Massamiri , Edward W. Randell und Khosrow Adeli EMAIL logo
Veröffentlicht/Copyright: 19. September 2022
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM) Band 61 Heft 1

Abstract

Objectives

Clinical laboratory investigation of autoimmune, metabolic, and oncologic disorders in children and adolescents relies on appropriateness of reference intervals (RIs). The Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) previously established comprehensive pediatric RIs for specialized immunoassays on the Abbott ARCHITECT system. Herein, we aim to verify performance on new Alinity i assays by evaluating sera collected from healthy children as per Clinical and Laboratory Standards Institute (CLSI) EP-28A3C guidelines.

Methods

Precision, linearity, and method comparison experiments were completed for 17 specialized Alinity immunoassays, including cancer antigens, autoimmune peptides, and hormones. Sera collected from healthy children and adolescents (birth-18 years, n=100) were evaluated. CLSI-based verification was completed using previously established CALIPER RIs for ARCHITECT assays as the reference.

Results

Of 17 specialized immunoassays assays, only anti-cyclic citrullinated peptides (anti-CCP) did not meet acceptable verification criterion (i.e., ≥90% of results within ARCHITECT reference CI). Anti-thyroglobulin, anti-thyroid peroxidase, and carcinoembryonic antigen did not require age-specific consideration beyond one year of age, with 63, 91, and 80% of samples equalling the limit of detection, respectively. Estimates were separated by sex for relevant assays (e.g., sex hormone binding globulin, total and free prostate specific antigen).

Conclusions

Findings support transferability of pediatric RIs on ARCHITECT system to the Alinity system for 16 specialized immunoassays in the CALIPER cohort and will be a useful resource for pediatric clinical laboratories using Alinity assays. Further work is needed to establish evidence-based interpretative recommendations for anti-CCP and continue to evaluate pediatric RI acceptability for newly available assay technologies.

Keywords: Abbott Alinity; CALIPER; pediatric reference interval; specialized immunoassay; verification
Corresponding author: Khosrow Adeli, CALIPER Program, Molecular Medicine, Research Institute and the Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8 Canada; and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, Phone: 416-813-8682, E-mail:

Funding source: Canadian Institutes of Health Research

Award Identifier / Grant number: 353989

Funding source: Abbott Diagnostics

Acknowledgments

We would like to thank CALIPER participants and families without whom this work would not have been possible. We would also like to thank Dr. Vathany Kulasingam (University Hospital Network, Toronto, ON, Canada) and Dr. Amy Lou (Nova Scotia Health, Halifax, NS, Canada) for their assistance with method comparison analysis. We would like to acknowledge Abbott Diagnostics for providing reagent and funding support.

  1. Research funding: This work was supported by a Canadian Institutes for Health Research (CIHR) Foundation Grant, a research grant from Abbott Diagnostics USA, a CIHR Doctoral Scholarship (awarded to Mary Kathryn Bohn), and a CIHR Masters Scholarship and a Banting and Best Diabetes Centre Graduate Studentship (awarded to Siobhan Wilson).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Study was approved by the Research Ethics Board at The Hospital for Sick Children.

References

1. Adeli, K, Higgins, V, Trajcevski, K, Palmert, MR. Important considerations for interpreting biochemical tests in children. BMJ 2018;361:k1950. https://doi.org/10.1136/bmj.k1950.Suche in Google Scholar PubMed

2. Adeli, K, Higgins, V, Trajcevski, K, White-Al Habeeb, N. The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper. Crit Rev Clin Lab Sci 2017;54:358–413. https://doi.org/10.1080/10408363.2017.1379945.Suche in Google Scholar PubMed

3. Hoq, M, Matthews, S, Karlaftis, V, Burgess, J, Cowley, J, Donath, S, et al.. Reference values for 30 common biochemistry analytes across 5 different analyzers in neonates and children 30 days to 18 years of age. Clin Chem 2019;65:1317–26. https://doi.org/10.1373/clinchem.2019.306431.Suche in Google Scholar PubMed

4. Karbasy, K, Ariadne, P, Gaglione, S, Nieuwesteeg, M, Adeli, K. Advances in pediatric reference intervals for biochemical markers: establishment of the caliper database in healthy children and adolescents. J Med Biochem 2015;34:23–30.10.2478/jomb-2014-0063Suche in Google Scholar PubMed PubMed Central

5. Zierk, J, Arzideh, F, Rechenauer, T, Haeckel, R, Rascher, W, Metzler, M, et al.. Age- and sex-specific dynamics in 22 hematologic and biochemical analytes from birth to adolescence. Clin Chem 2015;61:964–73. https://doi.org/10.1373/clinchem.2015.239731.Suche in Google Scholar PubMed

6. Hilsted, L, Rustad, P, Aksglæde, L, Sorensen, K, Juul, A. Recommended Nordic paediatric reference intervals for 21 common biochemical properties. Scand J Clin Lab Invest 2013;73:1–9. https://doi.org/10.3109/00365513.2012.721519.Suche in Google Scholar PubMed

7. Karbasy, K, Lin, DCC, Stoianov, A, Chan, MK, Bevilacqua, V, Chen, Y, et al.. Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children. Clin Chem Lab Med 2015;54:643–57. https://doi.org/10.1515/cclm-2015-0558.Suche in Google Scholar PubMed

8. Colantonio, DA, Kyriakopoulou, L, Chan, MK, Daly, CH, Brinc, D, Venner, AA, et al.. Closing the gaps in pediatric laboratory reference intervals: a caliper database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68. https://doi.org/10.1373/clinchem.2011.177741.Suche in Google Scholar PubMed

9. Konforte, D, Shea, JL, Kyriakopoulou, L, Colantonio, D, Cohen, AH, Shaw, J, et al.. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals. Clin Chem 2013;59:1215–27. https://doi.org/10.1373/clinchem.2013.204123.Suche in Google Scholar PubMed

10. Bailey, D, Colantonio, D, Kyriakopoulou, L, Cohen, AH, Chan, MK, Armbruster, D, et al.. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013;59:1393–405. https://doi.org/10.1373/clinchem.2013.204222.Suche in Google Scholar PubMed

11. Kelly, J, Raizman, JE, Bevilacqua, V, Chan, MK, Chen, Y, Quinn, F, et al.. Complex reference value distributions and partitioned reference intervals across the pediatric age range for 14 specialized biochemical markers in the CALIPER cohort of healthy community children and adolescents. Clin Chim Acta 2015;450:196–202. https://doi.org/10.1016/j.cca.2015.08.020.Suche in Google Scholar PubMed

12. Estey, MP, Cohen, AH, Colantonio, DA, Chan, MK, Marvasti, TB, Randell, E, et al.. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013;46:1197–219. https://doi.org/10.1016/j.clinbiochem.2013.04.001.Suche in Google Scholar PubMed

13. Higgins, V, Truong, D, Woroch, A, Chan, MK, Tahmasebi, H, Adeli, K. CLSI-based transference and verification of CALIPER pediatric reference intervals for 29 Ortho VITROS 5600 chemistry assays. Clin Biochem 2018;53:93–103. https://doi.org/10.1016/j.clinbiochem.2017.12.011.Suche in Google Scholar PubMed

14. Bohn, MK, Higgins, V, Asgari, S, Leung, F, Hoffman, B, Macri, J, et al.. Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents. Clin Chem Lab Med 2019;57:1968–79.10.1515/cclm-2019-0707Suche in Google Scholar PubMed

15. Higgins, V, Chan, MK, Nieuwesteeg, M, Hoffman, BR, Bromberg, IL, Gornall, D, et al.. Transference of CALIPER pediatric reference intervals to biochemical assays on the Roche cobas 6000 and the Roche Modular P. Clin Biochem 2016;49:139–49. https://doi.org/10.1016/j.clinbiochem.2015.08.018.Suche in Google Scholar PubMed

16. Higgins, V, Fung, AWS, Chan, MK, Macri, J, Adeli, K. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents. Clin Chem Lab Med 2018;56:327–40. https://doi.org/10.1515/cclm-2017-0349.Suche in Google Scholar PubMed

17. Plebani, M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013;51:741–51. https://doi.org/10.1515/cclm-2013-0075.Suche in Google Scholar PubMed

18. Horowitz, GL, Altaie, S, Boyd, JC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd ed. Wayne, PA, USA: CLSI; 2010.Suche in Google Scholar

19. Bohn, MK, Wilson, S, Hall, A, Adeli, K. Pediatric reference interval verification for endocrine and fertility hormone assays on the Abbott Alinity system. Clin Chem Lab Med 2021;59:1680–7. https://doi.org/10.1515/cclm-2021-0337.Suche in Google Scholar PubMed

20. Bohn, MK, Wilson, S, Hall, A, Massamiri, Y, Randell, E, Adeli, K. Pediatric reference interval verification for common biochemical assays on the Abbott Alinity system. Clin Chem Lab Med 2021;59:1554–62. https://doi.org/10.1515/cclm-2021-0336.Suche in Google Scholar PubMed PubMed Central

21. Bevilacqua, V, Chan, MK, Chen, Y, Armbruster, D, Schodin, B, Adeli, K. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. Clin Chem 2014;60:1532–42. https://doi.org/10.1373/clinchem.2014.229799.Suche in Google Scholar PubMed

22. Konforte, D, Shea, JL, Kyriakopoulou, L, Colantonio, D, Cohen, AH, Shaw, J, et al.. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals. Clin Chem 2013;59:1215–27. https://doi.org/10.1373/clinchem.2013.204123.Suche in Google Scholar PubMed

23. EP05A3: Evaluating Quantitative Measurement Precision [Internet]. Available from: https://clsi.org/standards/products/method-evaluation/documents/ep05/ [Accessed 26 Jun 2020].Suche in Google Scholar

24. EP06-A Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline [Internet]. 2003. Available from: www.clsi.org [Accessed 26 Jun 2020].Suche in Google Scholar

25. Tamam, M, Uyanik, E, Edís, N, Mulazimoglu, M, Ozpacaci, T. Differentiated thyroid carcinoma in children: clinical characteristics and long-term follow-up. World J Nucl Med 2020;19:28. https://doi.org/10.4103/wjnm.wjnm_15_19.Suche in Google Scholar

26. Kaloumenou, I, Mastorakos, G, Alevizaki, M, Duntas, LH, Mantzou, E, Ladopoulos, C, et al.. Thyroid autoimmunity in schoolchildren in an area with long-standing iodine sufficiency: correlation with gender, pubertal stage, and maternal thyroid autoimmunity. Thyroid 2008;18:747–54. https://doi.org/10.1089/thy.2007.0370.Suche in Google Scholar PubMed

27. Karapanou, O, Tzanela, M, Rondogianni, P, Dacou-Voutetakis, C, Chiotis, D, Vlassopoulou, B, et al.. Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence. Endocrine 2020;70:566–74. https://doi.org/10.1007/s12020-020-02378-2.Suche in Google Scholar PubMed

28. Taubner, K, Schubert, G, Pulzer, F, Pfaeffle, R, Körner, A, Dietz, A, et al.. Serum concentrations of anti-thyroid peroxidase and anti-thyroglobulin antibodies in children and adolescents without apparent thyroid disorders. Clin Biochem 2014;47:3–7. https://doi.org/10.1016/j.clinbiochem.2013.09.017.Suche in Google Scholar PubMed

29. Haller-Kikkatalo, K, Alnek, K, Metspalu, A, Mihailov, E, Metsküla, K, Kisand, K, et al.. Demographic associations for autoantibodies in disease-free individuals of a European population. Sci Rep 2017;7:1–12. https://doi.org/10.1038/srep44846.Suche in Google Scholar PubMed PubMed Central

30. D’Aurizio, F, Metus, P, Ferrari, A, Caruso, B, Castello, R, Villalta, D, et al.. Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods. Autoimmun Highlights 2017;8:1–10. https://doi.org/10.1007/s13317-017-0096-3.Suche in Google Scholar PubMed PubMed Central

31. Tozzoli, R, D’Aurizio, F, Ferrari, A, Castello, R, Metus, P, Caruso, B, et al.. The upper reference limit for thyroid peroxidase autoantibodies is method-dependent: a collaborative study with biomedical industries. Clin Chim Acta 2016;452:61–5. https://doi.org/10.1016/j.cca.2015.10.025.Suche in Google Scholar PubMed

32. Pauniaho, S-L, Tatti, O, Lahdenne, P, Lindahl, H, Pakarinen, M, Rintala, R, et al.. Tumor markers AFP, CA 125, and CA 19-9 in the long-term follow-up of Sacrococcygeal teratomas in infancy and childhood. Tumor Biol 2010;31:261–5. https://doi.org/10.1007/s13277-010-0026-8.Suche in Google Scholar PubMed

33. Birgen, D, Ertem, U, Duru, F, Şahin, G, Yüksek, N, Bozkurt, C, et al.. Serum Ca 125 levels in children with acute leukemia and lymphoma. Leuk Lymphoma 2005;46:1177–81. https://doi.org/10.1080/10428190500096690.Suche in Google Scholar PubMed

34. Duffy, MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract 2013;22:4–11. https://doi.org/10.1159/000338393.Suche in Google Scholar PubMed PubMed Central

35. Tanguay, S, Bégin, LR, Elhilali, MM, Behlouli, H, Karakiewicz, PI, Aprikian, AG. Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 2002;59:261–5. https://doi.org/10.1016/s0090-4295(01)01497-2.Suche in Google Scholar PubMed

36. Kim, MR, Gupta, MK, Travers, SH, Rogers, DG, Van Lente, F, Faiman, C. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys. Clin Endocrinol 1999;50:203–10. https://doi.org/10.1046/j.1365-2265.1999.00636.x.Suche in Google Scholar PubMed

37. Saad, A, Man, CD, Nandy, DK, Levine, JA, Bharucha, AE, Rizza, RA, et al.. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 2012;61:2691–700. https://doi.org/10.2337/db11-1478.Suche in Google Scholar PubMed PubMed Central

38. Tebo, AE, Jaskowski, T, Davis, KW, Whiting, A, Clifford, B, Zeft, A, et al.. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2012;10. https://doi.org/10.1186/1546-0096-10-29.Suche in Google Scholar PubMed PubMed Central

39. Abbott, Diagnostics. Anti-CCP Reagent Information for Use. 2018. [Accessed 15 Sep 2022].Suche in Google Scholar

40. Lipinska, J, Lipinska, S, Kasielski, M, Smolewska, E. Anti-MCV and anti-CCP antibodies—diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA). Clin Rheumatol 2016;35:2699–706. https://doi.org/10.1007/s10067-016-3355-1.Suche in Google Scholar PubMed

Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0709).

Received: 2022-07-21
Accepted: 2022-09-09
Published Online: 2022-09-19
Published in Print: 2023-01-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. A new milestone on the road to global standardization of apolipoprotein measurements
  4. Review
  5. Saliva – a new opportunity for fluid biopsy
  6. Opinion Papers
  7. Emerging technology: a definition for laboratory medicine
  8. The next wave of innovation in laboratory automation: systems for auto-verification, quality control and specimen quality assurance
  9. EFLM Paper
  10. The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  11. Guidelines and Recommendations
  12. Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results
  13. General Clinical Chemistry and Laboratory Medicine
  14. Quantitative protein mass-spectrometry requires a standardized pre-analytical phase
  15. Report from the HarmoSter study: inter-laboratory comparison of LC-MS/MS measurements of corticosterone, 11-deoxycortisol and cortisone
  16. The influence of proteoforms: assessing the accuracy of total vitamin D-binding protein quantification by proteolysis and LC-MS/MS
  17. Total serum vitamin B12 (cobalamin) LC-MS/MS assay as an arbiter of clinically discordant immunoassay results
  18. The preanalytical process in the emergency department, a European survey
  19. Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements
  20. Umbilical cord blood gases: probability of arterial or venous source in acidemia
  21. Reference Values and Biological Variations
  22. Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents
  23. Hematology and Coagulation
  24. Performance of digital morphology analyzer CellaVision DC-1
  25. Cancer Diagnostics
  26. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management
  27. Cardiovascular Diseases
  28. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study
  29. Infectious Diseases
  30. A novel scoring system combining Modified Early Warning Score with biomarkers of monocyte distribution width, white blood cell counts, and neutrophil-to-lymphocyte ratio to improve early sepsis prediction in older adults
  31. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service
  32. Acknowledgment
  33. Acknowledgment
  34. Letters to the Editor
  35. About the estimation of albuminuria based on proteinuria results
  36. Response to “About the estimation of albuminuria based on proteinuria results”
  37. Reply to Abildgaard et al.: lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA1c POCT instrument in a true clinical setting
  38. Reply to letter from Mayfield et al. regarding “Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting”
  39. High-sensitive cardiac troponin T: are turbulences coming?
  40. Analytical performance evaluation of bioactive adrenomedullin on point-of-care platform
  41. Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV2 mRNA or vector vaccine
  42. Neopterin level can be measured by intraocular liquid biopsy
  43. The stability of pleural fluid pH under slushed ice and room temperature conditions
https://doi.org/10.1515/cclm-2022-0709
Schlagwörter für diesen Artikel
Abbott Alinity; CALIPER; pediatric reference interval; specialized immunoassay; verification

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. A new milestone on the road to global standardization of apolipoprotein measurements
  4. Review
  5. Saliva – a new opportunity for fluid biopsy
  6. Opinion Papers
  7. Emerging technology: a definition for laboratory medicine
  8. The next wave of innovation in laboratory automation: systems for auto-verification, quality control and specimen quality assurance
  9. EFLM Paper
  10. The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  11. Guidelines and Recommendations
  12. Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results
  13. General Clinical Chemistry and Laboratory Medicine
  14. Quantitative protein mass-spectrometry requires a standardized pre-analytical phase
  15. Report from the HarmoSter study: inter-laboratory comparison of LC-MS/MS measurements of corticosterone, 11-deoxycortisol and cortisone
  16. The influence of proteoforms: assessing the accuracy of total vitamin D-binding protein quantification by proteolysis and LC-MS/MS
  17. Total serum vitamin B12 (cobalamin) LC-MS/MS assay as an arbiter of clinically discordant immunoassay results
  18. The preanalytical process in the emergency department, a European survey
  19. Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements
  20. Umbilical cord blood gases: probability of arterial or venous source in acidemia
  21. Reference Values and Biological Variations
  22. Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents
  23. Hematology and Coagulation
  24. Performance of digital morphology analyzer CellaVision DC-1
  25. Cancer Diagnostics
  26. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management
  27. Cardiovascular Diseases
  28. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study
  29. Infectious Diseases
  30. A novel scoring system combining Modified Early Warning Score with biomarkers of monocyte distribution width, white blood cell counts, and neutrophil-to-lymphocyte ratio to improve early sepsis prediction in older adults
  31. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service
  32. Acknowledgment
  33. Acknowledgment
  34. Letters to the Editor
  35. About the estimation of albuminuria based on proteinuria results
  36. Response to “About the estimation of albuminuria based on proteinuria results”
  37. Reply to Abildgaard et al.: lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA1c POCT instrument in a true clinical setting
  38. Reply to letter from Mayfield et al. regarding “Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting”
  39. High-sensitive cardiac troponin T: are turbulences coming?
  40. Analytical performance evaluation of bioactive adrenomedullin on point-of-care platform
  41. Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV2 mRNA or vector vaccine
  42. Neopterin level can be measured by intraocular liquid biopsy
  43. The stability of pleural fluid pH under slushed ice and room temperature conditions
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 1.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0709/html?lang=de
Button zum nach oben scrollen